Mercedes
Iñarrairaegui Bastarrica
Consultora Médica
Instituto de Investigación Sanitaria de Navarra
Pamplona, EspañaPublicacions en col·laboració amb investigadors/es de Instituto de Investigación Sanitaria de Navarra (19)
2024
-
Comprehensive in silico CpG methylation analysis in hepatocellular carcinoma identifies tissue- and tumor-type specific marks disconnected from gene expression
Journal of Physiology and Biochemistry
-
Prognostic value of ultra-low-pass whole-genome sequencing of circulating tumor DNA in hepatocellular carcinoma under systemic treatment
Clinical and Molecular Hepatology, Vol. 30, Núm. 2, pp. 177-190
-
The Impact of Portal Hypertension Assessment Method on the Outcomes of Hepatocellular Carcinoma Resection: A Meta-Analysis of Matched Cohort and Prospective Studies
Annals of Surgery, Vol. 280, Núm. 1, pp. 46-55
2023
2022
-
A new animal model of atrophy–hypertrophy complex and liver damage following Yttrium-90 lobar selective internal radiation therapy in rabbits
Scientific Reports, Vol. 12, Núm. 1
-
Evaluation of the quality of multiple-choice questions according to the students’ academic level
BMC Medical Education, Vol. 22, Núm. 1
-
Neoantigens as potential vaccines in hepatocellular carcinoma
Journal for ImmunoTherapy of Cancer, Vol. 10, Núm. 2
-
Pure laparoscopic major liver resection after yttrium90 radioembolization: a case-matched series analysis of feasibility and outcomes
Langenbeck's Archives of Surgery, Vol. 407, Núm. 3, pp. 1099-1111
2021
-
Web-based formative assessment through clinical cases: role in pathophysiology teaching
BMC Medical Education, Vol. 21, Núm. 1
2020
-
The Pattern of Progression Defines Post-progression Survival in Patients with Hepatocellular Carcinoma Treated with SIRT
CardioVascular and Interventional Radiology, Vol. 43, Núm. 8, pp. 1165-1172
2017
-
Conversion from calcineurin Inhibitor-Based immunosuppression to mycophenolate mofetil in monotherapy reduces risk of de novo malignancies after liver transplantation
Annals of Transplantation, Vol. 22, pp. 141-147
-
NatB-mediated protein N-α-terminal acetylation is a potential therapeutic target in hepatocellular carcinoma
Oncotarget, Vol. 8, Núm. 25, pp. 40967-40981
-
Phase 1–2 pilot clinical trial in patients with decompensated liver cirrhosis treated with bone marrow–derived endothelial progenitor cells
Translational Research, Vol. 188, pp. 80-91.e2
-
Totally laparoscopic right hepatectomy for living donor liver transplantation: Analysis of a preliminary experience on 5 consecutive cases
Transplantation, Vol. 101, Núm. 3, pp. 548-554
2016
-
Factors related to increased resting energy expenditure in men with liver cirrhosis
European Journal of Gastroenterology and Hepatology, Vol. 28, Núm. 2, pp. 139-145
2015
-
Clinical testing of a dendritic cell targeted therapeutic vaccine in patients with chronic hepatitis C virus infection
Molecular Therapy - Methods and Clinical Development, Vol. 2, pp. 15006
-
Immune monitoring of immunosuppression withdrawal of liver transplant recipients
Transplant Immunology, Vol. 33, Núm. 2, pp. 110-116
-
Pilot randomized trial of selective internal radiation therapy vs. chemoembolization in unresectable hepatocellular carcinoma
Liver International, Vol. 35, Núm. 6, pp. 1715-1721
-
Radioembolization with 90Y-microspheres for liver tumors
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 34, Núm. 4, pp. 244-257